Open Journal of Proteomics and Genomics Submit Manuscript

    A sirtuin 6 activator in the pipeline: New perspectives in depressive disorder treatment

    DOI Logo 10.17352/ojpg.000013

    Published On: April 30, 2024 | Pages: 001 - 004

    Author(s): Ana Carolina de Oliveira Pereira, Gabriel Almeida Mendonça da Silva, José C. Barros and Raoni Schroeder Borges Gonçalves*

    ORCID Logo  0000-0003-1305-9434

    Major Depressive Disorder (MDD) is among the most prevalent mental illnesses worldwide. Its symptoms include persistent feelings of sadness, loss of interest in previously enjoyed activities, and a lack of motivation for daily tasks. While FDA-approved medications are available, they often come with side effects, especially those targeting monoamine neurotransmitters ... CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat
    Abstract View Full Article View